The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma-Reference-Cited by-同舟云学术

The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma

Published:2015-11-02 Issue:21 Volume:14 Page:3418-3429
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Banelli Barbara¹,Carra Elisa²,Barbieri Federica³,Würth Roberto³,Parodi Federica¹,Pattarozzi Alessandra³,Carosio Roberta¹,Forlani Alessandra¹,Allemanni Giorgio¹,Marubbi Daniela²⁴,Florio Tullio³,Daga Antonio²,Romani Massimo¹

Affiliation:

1. Laboratory of Tumor Epigenetics; IRCCS AOU San Martino – IST; Genova, Italy

2. Laboratory of Regenerative Medicine; IRCCS AOU San Martino - IST; Genova, Italy

3. Section of Pharmacology; Department of Internal Medicine and Center of Excellence for Biomedical Research (CEBR); University of Genova; Genova, Italy

4. Department of Experimental Medicine (DIMES); University of Genova; Genova, Italy

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2015.1090063

Reference55 articles.

1. Emerging insights into the molecular and cellular basis of glioblastoma

2. Brain tumor stem cells: The cancer stem cell hypothesis writ large

3. Glioma Stem Cells: Their Role in Chemoresistance

4. The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells

5. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

2. Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes;Current Oncology;2024-07-12

3. Epigenetic regulation of tumor-immune symbiosis in glioma;Trends in Molecular Medicine;2024-05

4. Mechanistic QSAR modeling derived virtual screening, drug repurposing, ADMET and in - vitro evaluation to identify anticancer lead as lysine-specific demethylase 5a inhibitor;Journal of Biomolecular Structure and Dynamics;2024-02-22

5. KDM5B predicts temozolomide-resistant subclones in glioblastoma;iScience;2024-01